Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) affects 25% of the adult population globally. Since liver fibrosis is the most important predictor of liver-related complications in patients with NAFLD, identification of patients with advanced fibrosis among at-risk individuals is an important issue in cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Irvine, Katharine M., Okano, Satomi, Patel, Preya J., Horsfall, Leigh U., Williams, Suzanne, Russell, Anthony, Powell, Elizabeth E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858627/
https://www.ncbi.nlm.nih.gov/pubmed/33536476
http://dx.doi.org/10.1038/s41598-021-82315-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858627/
https://www.ncbi.nlm.nih.gov/pubmed/33536476
http://dx.doi.org/10.1038/s41598-021-82315-z

Ejemplares similares